semaglutide shortage ending Ozempic and Wegovy are no longer in shortage, FDA says 🚨 FDA Moves to Permanently

From injectable medications to supplement-based GLP-1 support products, these interventions can meaningfully reduce appetite, improve glycemic control, and accelerate weight loss

doi: 10.1056/NEJMoa2410027

Access and Affordability Many payers prefer generics, so generic liraglutide may see faster formulary adoption and fewer steptherapy barriers compared with brands

Kod mnogih ljudi, zbog loe ishrane, stresa - GLP-1 ne radi kako bi trebao

Mounjaro (tirzepatide, Eli Lilly) launched in India in March 2025 and is still on-patent, so theres no generic competing it down yet thats not expected until around 202728

BPC-157 comes in two forms: Subcutaneous injection Oral capsule Interestingly, BPC-157 is one of the only peptides available in an effective oral capsule form, likely because of its natural affinity for the gastrointestinal tract